The p38 mitogen-activated protein kinase (MAPK) pathway is an important mediator of cellular responses to environmental stress. Targets of p38 include transcription factors, components of the translational machinery, and downstream serine/threonine kinases, including MAPK-activated protein kinase 5 (MK5). Here we have used enhanced green fluorescent protein fusion proteins to analyze the subcellular localization of MK5. Although this protein is predominantly nuclear in unstimulated cells, MK5 shuttles between the nucleus and the cytoplasm. Furthermore, we have shown that the C-terminal domain of MK5 contains both a functional nuclear localization signal (NLS) and a leucine-rich nuclear export signal (NES), indicating that the subcellular distribution of this kinase reflects the relative activities of these two signals. In support of this, we have shown that stress-induced activation of the p38 MAPK stimulates the chromosomal region maintenance 1 protein-dependent nuclear export of MK5. This is regulated by both binding of p38 MAPK to MK5, which masks the functional NLS, and stress-induced phosphorylation of MK5 by p38 MAPK, which either activates or unmasks the NES. These properties may define the ability of MK5 to differentially phosphorylate both nuclear and cytoplasmic targets or alternatively reflect a mechanism whereby signals initiated by activation of MK5 in the nucleus may be transmitted to the cytoplasm.The mammalian p38 mitogen-activated protein kinase (MAPK) pathway is activated by UV radiation, sodium arsenite, heat shock, bacterial lipopolysaccharide, and proinflammatory cytokines and is an important mediator of the cellular response to environmental stress (18,26,39). Among the cellular responses to p38 signaling are the production of inflammatory cytokines and phosphorylation of the small heat shock proteins. The physiological processes affected by p38 signaling include cell cycle progression, differentiation, apoptosis, and the inflammatory response. In addition, studies of Drosophila, Xenopus, and mouse have revealed important roles for p38 MAPK signaling during early development (32).Four distinct p38 MAPKs have been identified in mammalian cells: p38␣ (stress-activated protein kinase 2a [SAPK2a]), p38␤ (SAPK2b), p38␥ (SAPK3), and p38␦ (SAPK4). These enzymes are all phosphorylated and activated by MAPK kinase 6 (MKK6) (15). A second MKK, MKK3, is able to activate p38␣, p38␥, and p38␦, but not p38␤ (49). The four p38 MAPK isoforms are 60 to 70% identical at the amino acid sequence level and have overlapping substrate specificities in vitro. This has made the identification of physiological substrates and functions for p38 MAPKs a difficult task. However, the discovery that p38␣ and p38␤, but not p38␥ or 38␦, are inhibited by the pyridinyl imidazole SB203580 coupled with the more recent generation of mice which lack either individual p38 MAPKs or their upstream activators has proven extremely useful in delineating functional pathways for these enzymes (6,25,29,32) Targets of the p38 pathway inclu...

BackgroundThe transcription factor PAX6 is expressed in various cancers. In anaplastic astrocytic glioma, PAX6 expression is inversely related to tumor grade, resulting in low PAX6 expression in Glioblastoma, the highest-grade astrocytic glioma. The aim of the present study was to develop a PAX6 knock out cell line as a tool for molecular studies of the roles PAX6 have in attenuating glioblastoma tumor progression.MethodsThe CRISPR-Cas9 technique was used to knock out PAX6 in U251 N cells. Viral transduction of a doxycycline inducible EGFP-PAX6 expression vector was used to re-introduce (rescue) PAX6 expression in the PAX6 knock out cells. The knock out and rescued cells were rigorously characterized by analyzing morphology, proliferation, colony forming abilities and responses to oxidative stress and chemotherapeutic agents.ResultsThe knock out cells had increased proliferation and colony forming abilities compared to wild type cells, consistent with clinical observations indicating that PAX6 functions as a tumor-suppressor. Cell cycle distribution and sensitivity to H2O2 induced oxidative stress were further studied, as well as the effect of different chemotherapeutic agents. For the PAX6 knock out cells, the percentage of cells in G2/M phase increased compared to PAX6 control cells, indicating that PAX6 keeps U251 N cells in the G1 phase of the cell cycle. Interestingly, PAX6 knock out cells were more resilient to H2O2 induced oxidative stress than wild type cells. Chemotherapy treatment is known to generate oxidative stress, hence the effect of several chemotherapeutic agents were tested. We discovered interesting differences in the sensitivity to chemotherapeutic drugs (Temozolomide, Withaferin A and Sulforaphane) between the PAX6 expressing and non-expressing cells.ConclusionsThe U251 N PAX6 knock out cell lines generated can be used as a tool to study the molecular functions and mechanisms of PAX6 as a tumor suppressor with regard to tumor progression and treatment of glioblastoma.Electronic supplementary materialThe online version of this article (10.1186/s12885-018-4394-6) contains supplementary material, which is available to authorized users.

The Pathology Atlas is an open-access database that reports the prognostic value of protein-coding transcripts in 17 cancers, including head and neck cancer. However, cancers of the various head and neck anatomical sites are specific biological entities. Thus, the aim of the present study was to validate promising prognostic markers for head and neck cancer reported in the Pathology Atlas in oral tongue squamous cell carcinoma (OTSCC). We selected three promising markers from the Pathology Atlas (CALML5, CD59, LIMA1), and analyzed their prognostic value in a Norwegian OTSCC cohort comprising 121 patients. We correlated target protein and mRNA expression in formalin-fixed, paraffin-embedded cancer tissue to five-year disease-specific survival (DSS) in univariate and multivariate analyses. Protein expression of CALML5 and LIMA1 were significantly associated with five-year DSS in the OTSCC cohort in univariate analyses (p = 0.016 and p = 0.043, respectively). In multivariate analyses, lymph node metastases, tumor differentiation, and CALML5 were independent prognosticators. The prognostic role of the other selected markers for head and neck cancer patients identified through unbiased approaches could not be validated in our OTSCC cohort. This underlines the need for subsite-specific analyses for head and neck cancer.

Serglycin is a proteoglycan highly expressed by immune cells, in which its functions are linked to storage, secretion, transport, and protection of chemokines, proteases, histamine, growth factors, and other bioactive molecules. In recent years, it has been demonstrated that serglycin is also expressed by several other cell types, such as endothelial cells, muscle cells, and multiple types of cancer cells. Here, we show that serglycin expression is upregulated in transforming growth factor beta (TGF-β) induced epithelial-mesenchymal transition (EMT). Functional studies provide evidence that serglycin plays an important role in the regulation of the transition between the epithelial and mesenchymal phenotypes, and it is a significant EMT marker gene. We further find that serglycin is more expressed by breast cancer cell lines with a mesenchymal phenotype as well as the basal-like subtype of breast cancers. By examining immune staining and single cell sequencing data of breast cancer tissue, we show that serglycin is highly expressed by infiltrating immune cells in breast tumor tissue.

Fragments of DNA present in food and feed are taken up by the gastrointestinal tract (GIT) of mammals. The extent of uptake varies according to organism, study design and DNA source. This study explores the hypothesis that actively growing, as well as pregnant rats, are more likely to take up DNA from the GIT than mature animals due to the high demand for nutrients for tissue and organ development. Plasmid DNA (pDNA) was added to standard feed for growing, and pregnant rats. The young rats received one pDNA (50 μg) containing meal by gavage. Blood, organ and tissue samples were harvested at 2 h to 3 days post feeding (p.f). The pregnant females were fed pellets containing pDNA (100 μg) daily, starting at day 5 after established pregnancy. Females and foeti were killed at days 7 and 14 of gestation, and pups at the time of weaning. Genomic DNA was analyzed by PCR followed by Southern blot and real-time PCR. A 201 bp target sequence was detected in mesenteric lymph nodes, spleen, liver and pancreas from growing rats 2 h p.f. At 6 h, target DNA was detectable in the kidneys, and at three days p.f. in the liver. Target DNA was not detected in samples from pregnant rats, their foeti or pups. In conclusion, low level of feed introduced DNA could be transiently detected in organs of young, growing rats. However, indications of increased DNA uptake levels in the GIT of growing rats were not found